FDA label
What is atovaquone used for?
The FDA-approved uses of atovaquone, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for atovaquone lists this use: Prevention of Pneumocystis jirovecii Pneumonia.
Run it in Rivvi
Which 2027 plans near you dropped or restricted atovaquone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Atovaquone, suspension
Indications and Usage, quoted from the label by KVK-Tech, Inc. (ANDA210510). Cross-references to other label sections are left out.
Prevention of Pneumocystis jirovecii Pneumonia
Atovaquone oral suspension is indicated for the prevention of Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (aged 13 years and older) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX).
Treatment of Mild-to-Moderate Pneumocystis jirovecii Pneumonia:
Atovaquone oral suspension is indicated for the acute oral treatment of mild-to-moderate PCP in adults and adolescents (aged 13 years and older) who cannot tolerate TMP-SMX.
Source: DailyMed label, set id b31ff20a-c363-4be0-9bc0-3081c163b63c, version 8, effective June 16, 2026. NDC 10702-223, one of 22 listings for this product.
Questions
What is atovaquone used for?
The FDA label for atovaquone lists this use: Prevention of Pneumocystis jirovecii Pneumonia.
What drug class is atovaquone?
FDA lists atovaquone in the Antimalarial and Antiprotozoal established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.